Search BRITE hierarchies

Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
  L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
    L04 IMMUNOSUPPRESSANTS
      L04A IMMUNOSUPPRESSANTS
        L04AC Interleukin inhibitors
          L04AC07 Tocilizumab
            D02596  Tocilizumab (USAN/INN) <JP/US>

USP drug classification [BR:br08302]
  Immunological Agents
    Immunological Agents, Other
      Interleukin Blockers
        Tocilizumab
          D02596  Tocilizumab (USAN/INN)

Therapeutic category of drugs in Japan [BR:br08301]
  6  Agents against pathologic organisms and parasites
    63  Biological preparations
      639  Miscellaneous
        6399  Others
          D02596  Tocilizumab (USAN/INN); Tocilizumab (genetical recombination) (JAN)	L04AC07

Target-based classification of drugs [BR:br08310]
  Cytokines and receptors
    Cytokine receptors
      Interleukin receptors
        IL6R (CD126) [HSA:3570] [KO:K05055]
          D02596  Tocilizumab (USAN/INN) <JP/US>	Monoclonal antibody

[ BRITE | KEGG2 | KEGG ]